| Company Name: | Ashland Inc | | Ticker Symbol: | ASH | | | WWW Address: | www.ashland.com |
| CEO: | James J. O'Brien | | No. of Employees: | 15,000 |
| Common Issue Type: | CS | | Business Description: | Ashland Inc. is a global specialty chemicals company that provides products, services and solutions that meet customer needs throughout a variety of industries.
|
| | | Industry Information: | CHEMICALS - Chemicals - Major Diversified [more like this] |
| | Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 88.77 |  -0.33 | - | - | 88.18 | 88.79 | 87.61 | 989843 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 7,014.9 | 79.0 | 2.71 | 0.33 | 0.80 | 233.6 | 1.5 | 91.11 - 58.96 |
| | KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 88.77 | $ | | PE Ratio - LTM | 233.6 | |
| Market Capitalisation | 7,014.9 | mil |
| Latest Shares Outstanding | 79.0 | mil |
| Earnings pS (EPS) | 0.33 | $ |
| Dividend pS (DPS) | 0.80 | ¢ |
| Dividend Yield | 1.5 | % |
| Dividend Payout Ratio | 242 | % |
| Revenue per Employee | 547,067 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 69.8 | mil |
| Float as % of Shares Outstanding | 88.5 | % |
| Foreign Sales | 3,775 | mil |
| Domestic Sales | 4,431 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 21.70 | % |
| Research & Devlopment (R&D) as % of Revenue | 1.80 | % |
| Gross Profit Margin | 33.8 | % |
| EBITDA Margin | 10.3 | % |
| Pre-Tax Profit Margin | -0.3 | % |
| Assets Turnover | 0.6 | % |
| Return on Assets (ROA) | 0.3 | % |
| Return on Equity (ROE) | 0.7 | % |
| Return on Capital Invested (ROCI) | 0.4 | % |
| Current Ratio | 1.7 | |
| Leverage Ratio (Assets/Equity) | 2.9 | |
| Interest Cover | 0.9 | |
| Total Debt/Equity (Gearing Ratio) | 0.84 | |
| LT Debt/Total Capital | 42.0 | % |
| Working Capital pS | 16.13 | $ |
| Cash pS | 5.92 | $ |
| Book-Value pS | 52.60 | $ |
| Tangible Book-Value pS | -13.25 | $ |
| Cash Flow pS | 7.09 | $ |
| Free Cash Flow pS | 1.92 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.69 | |
| Price/Tangible Book Ratio | -6.70 | |
| Price/Cash Flow | 12.5 | |
| Price/Free Cash Flow | 46.2 | |
| P/E as % of Industry Group | 1,353.0 | % |
| P/E as % of Sector Segment | 1,032.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Dividend Declared Date | 05/14/2013 |
| Dividend Ex-Date | 05/28/2013 |
| Dividend Record Date | 05/30/2013 |
| Dividend Pay Date | 06/14/2013 |
| Dividend Amount | 340 |
| Type of Payment | Cash Payment |
| Dividend Rate | 1.36 |
| Current Dividend Yield | 1.5 |
| 5-Y Average Dividend Yield | 1.7 |
| Payout Ratio | 242.0 |
| 5-Y Average Payout Ratio | 68.0 |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | | | | | PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | -0.4 | 101 | 10,630 | 57,808 |
| 4 Weeks | 91.11 | 84.43 | 85.89 | 3.4 | 99 | 9,698 | 193,959 |
| 13 Weeks | 91.11 | 72.11 | 77.06 | 15.2 | 106 | 12,299 | 787,140 |
| 26 Weeks | 91.11 | 67.40 | 70.26 | 26.3 | 108 | 10,719 | 1,339,870 |
| 52 Weeks | 91.11 | 58.96 | 64.40 | 37.8 | 110 | 9,241 | 2,301,103 |
| YTD | 91.11 | 72.11 | - | 10.4 | 95 | 11,449 | 1,144,934 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 89.03 | 88.84 | 83.27 | 79.62 | 77.56 | 2.71 | 1.27 |
| | | | GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -1.36 | 6.0 | -2.30 |
| Income | -26.68 | 27.4 | -54.29 |
| Dividend | -0.86 | 0.1 | 32.18 |
| Capital Spending | 11.50 | NA | -31.63 |
| R&D | 0.00 | NA | 16.02 |
| Normalized Inc. | -28.37 | NA | -47.36 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -4.1 | -5.1 | 26.2 |
| Earnings % | 3.4 | -39.8 | -93.7 |
| EPS % | 2.7 | -40.0 | -93.6 |
| EPS $ | 0.05 | -0.44 | -4.84 |
| | | | SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 10.35 |
| Current Ratio | 1.7 |
| Quick Ratio (Acid Test) | 1.0 |
| Liquidity Ratio (Cash) | 0.27 |
| Receivables Turnover | 5.5 |
| Average Collection Period | 65 |
| Working Capital/Equity | 32.2 |
| Working Capital pS | 16.41 |
| Cash-Flow pS | 6.46 |
| Free Cash-Flow pS | 0.43 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 1.39 |
| Financial Leverage Ratio (Assets/Equity) | 3.1 |
| Debt Ratio | 67.8 |
| Total Debt/Equity (Gearing Ratio) | 0.89 |
| LT Debt/Equity | 0.78 |
| LT Debt/Capital Invested | 91.9 |
| LT Debt/Total Liabilities | 36.9 |
| Interest Cover | 0.9 |
| Interest/Capital Invested | 2.37 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 14.92 |
| Tobin's Q Ratio | 0.56 |
| Current P/E Ratio - LTM | 233.60 |
| Enterprise Value (EV)/EBITDA | 20.59 |
| Enterprise Value (EV)/Free Cash Flow | 432.29 |
| Dividend Yield | 1.5 |
| Price/Tangible Book Ratio - LTM | -6.70 |
| Price/Book Ratio - LTM | 1.69 |
| Price/Cash Flow Ratio | 12.5 |
| Price/Free Cash Flow Ratio - LTM | 46.2 |
| Price/Sales Ratio | 0.87 |
| P/E Ratio (1 month ago) - LTM | 229.4 |
| P/E Ratio (26 weeks ago) - LTM | 212.9 |
| P/E Ratio (52 weeks ago) - LTM | 41.3 |
| 5-Y High P/E Ratio | 237.2 |
| 5-Y Low P/E Ratio | 5.6 |
| 5-Y Average P/E Ratio | 58.7 |
| Current P/E Ratio as % of 5-Y Average P/E | 398 |
| P/E as % of Industry Group | 1,353.0 |
| P/E as % of Sector Segment | 1,032.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 167.5 |
| PER SHARE FIGURES |
| LT Debt pS | 39.63 |
| Current Liabilities pS | 24.22 |
| Tangible Book Value pS - LTM | -13.25 |
| Book Value pS - LTM | 52.60 |
| Capital Invested pS | 90.61 |
| Cash pS - LTM | 5.92 |
| Cash Flow pS - LTM | 7.09 |
| Free Cash Flow pS - LTM | 1.92 |
| Earnings pS (EPS) | 0.33 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 0.41 |
| Free Cash Flow Margin 5YEAR AVG | -7.77 |
| Net Profit Margin | 0.3 |
| Net Profit Margin - 5YEAR AVRG. | 2.5 |
| Equity Productivity | 2.04 |
| Return on Equity (ROE) | 0.6 |
| Return on Equity (ROE) - 5YEAR AVRG. | 5.4 |
| Capital Invested Productivity | 1.15 |
| Return on Capital Invested (ROCI) | 0.4 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 3.6 |
| Assets Productivity | 0.60 |
| Return on Assets (ROA) | 0.2 |
| Return on Assets (ROA) - 5YEAR AVRG. | 2.0 |
| Gross Profit Margin | 33.8 |
| Gross Profit Margin - 5YEAR AVRG. | 26.5 |
| EBITDA Margin - LTM | 10.3 |
| EBIT Margin - LTM | 3.7 |
| Pre-Tax Profit Margin | -0.2 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 2.0 |
| Effective Tax Rate | 371.4 |
| Effective Tax Rate - 5YEAR AVRG. | -257.7 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 128 |
| Revenue per Employee | 547,067 |
| Net Income per Employee | 1,733 |
| Average Collection Period | 65 |
| Receivables Turnover | 5.5 |
| Day's Inventory Turnover Ratio | 63 |
| Inventory Turnover | 5.7 |
| Inventory/Sales | 12.3 |
| Accounts Payble/Sales | 10.69 |
| Assets/Revenue | 1.67 |
| Net Working Capital Turnover | 6.33 |
| Fixed Assets Turnover | 0.88 |
| Total Assets Turnover | 0.6 |
| Revenue per $ Cash | 15.69 |
| Revenue per $ Plant | 2.90 |
| Revenue per $ Common Equity | 2.04 |
| Revenue per $ Capital Invested | 1.15 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 21.9 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 17.8 |
| Research & Devlopment (R&D) as % of Revenue | 1.7 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 1.7 |
|
|  
| | |  |  | |
| |
